Thiazolidinediones are associated with a decreased risk of atrial fibrillation compared with other antidiabetic treatment: a nationwide cohort study (Q39061640)

From Wikidata

Jump to navigation Jump to search

scientific article published on 8 November 2016

Language	Label	Description	Also known as
English	Thiazolidinediones are associated with a decreased risk of atrial fibrillation compared with other antidiabetic treatment: a nationwide cohort study	scientific article published on 8 November 2016

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Thiazolidinediones are associated with a decreased risk of atrial fibrillation compared with other antidiabetic treatment: a nationwide cohort study (English)

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

atrial fibrillation

0 references

Christian Torp-Pedersen

5

object named as

Christian Torp-Pedersen

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Gunnar Hilmar Gislason

7

object named as

Gunnar Hilmar Gislason

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Jonas Bjerring Olesen

4

object named as

Jonas Bjerring Olesen

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Morten Lock Hansen

6

object named as

Morten Lock Hansen

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

3

object named as

Laila Staerk

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Jannik Langtved Pallisgaard

1

object named as

Jannik Langtved Pallisgaard

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Tommi Bo Lindhardt

2

object named as

Tommi Bo Lindhardt

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

publication date

8 November 2016

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

European heart journal. Cardiovascular pharmacotherapy

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

140-146

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Meta-analysis of cohort and case-control studies of type 2 diabetes mellitus and risk of atrial fibrillation

1 reference

https://api.crossref.org/works/10.1093%2FEHJCVP%2FPVW036

21 January 2018

Risk factors for atrial fibrillation and their population burden in postmenopausal women: the Women's Health Initiative Observational Study

1 reference

https://api.crossref.org/works/10.1093%2FEHJCVP%2FPVW036

21 January 2018

Management and prognosis of atrial fibrillation in the diabetic patient.

1 reference

https://api.crossref.org/works/10.1093%2FEHJCVP%2FPVW036

21 January 2018

Risk of atrial fibrillation in diabetes mellitus: A nationwide cohort study

1 reference

https://api.crossref.org/works/10.1093%2FEHJCVP%2FPVW036

21 January 2018

Diabetes mellitus and atrial fibrillation: Pathophysiological mechanisms and potential upstream therapies

1 reference

https://api.crossref.org/works/10.1093%2FEHJCVP%2FPVW036

21 January 2018

Diabetes mellitus and atrial remodeling: mechanisms and potential upstream therapies

1 reference

https://api.crossref.org/works/10.1093%2FEHJCVP%2FPVW036

21 January 2018

Cardiac resynchronisation therapy response predicts occurrence of atrial fibrillation in non-ischaemic dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1093%2FEHJCVP%2FPVW036

21 January 2018

Mitochondrial oxidative stress promotes atrial fibrillation

1 reference

https://api.crossref.org/works/10.1093%2FEHJCVP%2FPVW036

21 January 2018

Thiazolidinediones and PPARγ agonists: time for a reassessment

1 reference

https://api.crossref.org/works/10.1093%2FEHJCVP%2FPVW036

21 January 2018

Anti-inflammatory actions of PPAR ligands: new insights on cellular and molecular mechanisms

1 reference

https://api.crossref.org/works/10.1093%2FEHJCVP%2FPVW036

21 January 2018

Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy

1 reference

https://api.crossref.org/works/10.1093%2FEHJCVP%2FPVW036

21 January 2018

Thiazolidinedione use and post-operative atrial fibrillation: a US nested case-control study

1 reference

https://api.crossref.org/works/10.1093%2FEHJCVP%2FPVW036

21 January 2018

Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1093%2FEHJCVP%2FPVW036

21 January 2018

Validity of the diagnoses atrial fibrillation and atrial flutter in a Danish patient registry.

1 reference

https://api.crossref.org/works/10.1093%2FEHJCVP%2FPVW036

21 January 2018

Diabetes patients requiring glucose-lowering therapy and nondiabetics with a prior myocardial infarction carry the same cardiovascular risk: a population study of 3.3 million people

1 reference

https://api.crossref.org/works/10.1093%2FEHJCVP%2FPVW036

21 January 2018

The Danish National Prescription Registry

1 reference

https://api.crossref.org/works/10.1093%2FEHJCVP%2FPVW036

21 January 2018

Identifiers

10.1093/EHJCVP/PVW036

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39061640&oldid=1833549815"